There is a certain kind of ambition that sounds good in speeches and fades quietly by the next budget cycle. Africa has had enough of that kind. What this continent needs — and what the Vaccine Access Initiative (VAI) is committed to delivering — is something far more demanding: disciplined, evidence-based execution.
Africa’s Health Sovereignty Is Not a Vision — It’s a Project Under Construction Read More »
Uganda has taken a significant step toward health industrialization and international scientific collaboration, signing a landmark Memorandum of Understanding (MoU) and Technology Transfer Agreement at Hacettepe University in Ankara, Türkiye.
Prof. Dr. Alexzander Asea, Chief Executive Officer of the Vaccine Access Initiative (VAI) a subsidiary of Microhaem Scientifics (MHS) was elected to the Board of the African Vaccine Manufacturing Initiative (AVMI), the continent’s principal platform shaping policy, advocacy, and investment alignment for sustainable vaccine manufacturing in Africa. AVMI operates at the intersection of government policy,
Strategic Governance Milestone: VAi Leadership Representation on the AVMI Board Read More »
